| __timestamp | United Therapeutics Corporation | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1288519000 | 580415000 |
| Thursday, January 1, 2015 | 1465761000 | 1032336000 |
| Friday, January 1, 2016 | 1598800000 | 1702177000 |
| Sunday, January 1, 2017 | 1725300000 | 2488652000 |
| Monday, January 1, 2018 | 1627800000 | 3047597000 |
| Tuesday, January 1, 2019 | 1448800000 | 4162821000 |
| Wednesday, January 1, 2020 | 1483300000 | 6205683000 |
| Friday, January 1, 2021 | 1685500000 | 7574400000 |
| Saturday, January 1, 2022 | 1936300000 | 8930700000 |
| Sunday, January 1, 2023 | 2327500000 | 9869200000 |
| Monday, January 1, 2024 | 11020100000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biopharmaceuticals, Vertex Pharmaceuticals Incorporated and United Therapeutics Corporation have shown remarkable revenue trajectories over the past decade. Since 2014, Vertex Pharmaceuticals has experienced a staggering growth, with its revenue increasing by over 1,600%, reaching nearly $9.9 billion by 2023. This growth is largely attributed to its innovative treatments and strategic market expansions.
On the other hand, United Therapeutics Corporation has demonstrated steady growth, with a 80% increase in revenue, culminating in approximately $2.3 billion in 2023. This consistent rise reflects its stronghold in the pulmonary arterial hypertension market.
The data highlights a significant divergence in growth rates, with Vertex Pharmaceuticals outpacing United Therapeutics by a factor of 20 in terms of revenue growth. This trend underscores the dynamic nature of the biopharmaceutical industry, where innovation and strategic positioning are key to financial success.
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated: Annual Revenue Growth Compared
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Vertex Pharmaceuticals Incorporated and argenx SE: A Comprehensive Revenue Analysis
Vertex Pharmaceuticals Incorporated vs Alnylam Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Vertex Pharmaceuticals Incorporated or Jazz Pharmaceuticals plc: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Vertex Pharmaceuticals Incorporated or Pharming Group N.V.?
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Corcept Therapeutics Incorporated
Revenue Insights: Vertex Pharmaceuticals Incorporated and ACADIA Pharmaceuticals Inc. Performance Compared
Revenue Insights: Vertex Pharmaceuticals Incorporated and Evotec SE Performance Compared
Revenue Insights: Vertex Pharmaceuticals Incorporated and Xencor, Inc. Performance Compared
GSK plc and United Therapeutics Corporation: A Comprehensive Revenue Analysis
United Therapeutics Corporation and ImmunityBio, Inc.: A Comprehensive Revenue Analysis